Aspirin/Pantoprazole Sodium Hydrate

阿司匹林/泮托拉唑钠

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAspirin/Pantoprazole Sodium Hydrate
Drug Alias NameAspirin and Pantoprazole Sodium Hydrate泮托拉唑钠/阿司匹林Aspirin/PantoprazolePantoprazole Sodium Hydrate and Aspirin
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsProton pump inhibitors
TargetsProton pumpCyclooxygenases
Therapy Area/IndicationsPeptic Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsYes AspirinPantoprazole Sodium Hydrate
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsPeptic Ulcer

Other Information

ATC CodeN/A
Related LinksN/A